Co-crystals
AssigneeLetavis AB
InventorsMihaela Maria POP, Paula VASILICHIA BULIERIS, Ingemar PONGRATZ, Victor FRUTH-OPRISAN, Raul-Augustin MITRAN
Life of this patent
Estimating the term…
Abstract
The present document is directed to co-crystals of resveratrol and/or curcumin with piperazine and their use in medicine and/or as food and feed supplements.
Claims61
A resveratrol-piperazine co-crystal, Form 1, characterized by having an XRPD pattern comprising peaks at 4.48, 13.32, 16.96, 18.88, 19.16, and 22.84 °2θ±0.2 °2θ.
The resveratrol-piperazine co-crystal, Form 1, according to any one of the preceding claims, characterized by having a fusion temperature Tfus of 201° C.±5° C.
The resveratrol-piperazine co-crystal, Form 1, according to any one of the preceding claims, characterized by having a DSC thermogram as shown in FIG. 2.
A method for producing the resveratrol-piperazine co-crystal, Form 1, as defined in any one of the preceding claims, said method comprising the steps of:
- a) dispensing resveratrol in acetone or acetonitrile;
- b) adding piperazine in acetone or acetonitrile to the dispensed resveratrol of step a) thereby providing a resveratrol-piperazine mixture;
- c) optionally diluting the resveratrol-piperazine mixture obtained in step b) with acetone or acetonitrile;
- d) heating the resveratrol-piperazine mixture obtained in step b) or c) at a temperature within the range of from about 30° C. to about 50° C. under stirring for about 10-30 minutes thereby providing a resveratrol-piperazine suspension;
- e) allowing the resveratrol-piperazine suspension obtained in step d) to settle;
- f) separating a solid phase obtained in step e);
- and
- g) drying the separated solid phase of step f).
A resveratrol-piperazine co-crystal, Form 2, characterized by having an XRPD pattern comprising peaks at 5.87, 12.74, 17.43, 17.70, 20.55, and 21.32 °2θ±0.2 °2θ.
A curcumin-piperazine co-crystal, Form 1, characterized by having an XRPD pattern comprising peaks at 4.60, 9.18, 11.31, 13.12, 14.73, 16.97, 22.98, and 24.66 °2θ±0.2 °2θ.
A curcumin-piperazine co-crystal, Form 2, characterized by having an XRPD pattern comprising peaks at 4.93, 9.46, 9.85, 13.98, 17.77, and 21.48 °2θ±0.2 °2θ.
A resveratrol-piperazine-curcumin co-crystal characterized by having an XRPD pattern comprising peaks at 4.26, 11.86, 16.78, 23.46, and 25.68 °2θ±0.2 °2θ.
Dependencies are inferred from the claim text.